This summer, agrochemical, biotechnology and seed giant Monsanto dropped its bid to acquire its Switzerland-based competitor, Syngenta. Initial merger serenades were sternly rebuffed by Syngenta, ...

Kevin Koch, the President and CEO of Edgewise Therapeutics , Inc. (NASDAQ:EWTX), a biotechnology company with a market capitalization of $2.5 billion, recently executed a series of stock transactions, ...

It isn’t just artificial intelligence. Chinese biotech companies are now developing drugs faster and cheaper than their US ...

IN8bio, Inc. (NASDAQ:INAB), a biotechnology firm specializing in cancer therapies, has been granted an additional 180 days to comply with Nasdaq's minimum bid price rule, as per a recent SEC filing.

New licensing Guidelines issued by the National Institutes of Health at the end of the Biden Administration could harm ...

For the past couple of weeks large rounds have barely trickled in, and this week continues that trend. Just three deals hit $100 million or more as investors seem to have pulled back on big rounds ...

Discover the latest developments in potential ALS treatments with COYA-302 and COYA-303, set to impact the $1.33 billion ...

Could you tell me about the firm? Mr. Kennedy: AllSource is a firm that focuses on high-net-worth and ultra-high-net-worth families, and we specialize in alternative investments. We like to say we ...

Deals, pipeline updates and geopolitical issues drove the conversation at the 2025 JP Morgan Healthcare conference.

Relmada, which has turned to strategic options after scrapping two phase 3 trials in major depressive disorder (MDD), is ...

With the Canadian economy experiencing a contraction in November and a recent interest rate cut by the Bank of Canada due to tariff uncertainties, investors are navigating a complex landscape. In such ...

The company owners, suspecting that the accused were bogus individuals posing as CBI personnel, reached out to the local ...